Skip to content
UK SIC 2007 72110 M ↗
● Official Registry Data: 2026-11-19

72110 — Research and experimental development on biotechnology

UK SIC 2007 72110 (Research and experimental development on biotechnology) classifies within economic division 72 (NACE Rev), linking EU/UN activity boundaries with US NAICS, UK SIC, and national regulatory obligations.

01 / Standard & Revision
UK SIC 2007

UK ONS / Companies House • v2007

02 / Parent Hierarchy
M

Professional, scientific and technical activities

03 / Mapped Standards
2

GB

04 / Subclasses & Scope
8 Items

MCC 8731

01 / OFFICIAL SCOPE & OPERATORS

Activity Scope, Operators & Exclusions

Includes official parent class explanatory notes from NACE Rev. 2 72.11

Who Uses This Code & Typical Business Models

  • Biotech, pharma discovery, AI/quantum, materials, and engineering R&D firms (72.10)
  • Contract Research Organizations (CROs), university spinouts, and deep-tech labs
  • Social sciences, humanities, and policy research institutes (72.20)

This Class Includes

8
  • Research and experimental development on biotechnology
  • DNA/RNA: genomics, pharmacogenomics, gene probes, genetic engineering, DNA/RNA sequencing/synthesis/amplification, gene expression profiling, and use of antisense technology
  • proteins and other molecules: sequencing/synthesis/engineering of proteins and peptides (including large molecule hormones); improved delivery methods for large molecule drugs; proteomics, protein isolation and purification, signalling, identification of cell receptors
  • cell and tissue culture and engineering: cell/tissue culture, tissue engineering (including tissue scaffolds and biomedical engineering), cellular fusion, vaccine/immune stimulants, embryo manipulation
  • process biotechnology techniques: fermentation using bioreactors, bioprocessing, bioleaching, biopulping, biobleaching, biodesulphurisation, bioremediation, biofiltration and phytoremediation
  • gene and RNA vectors: gene therapy, viral vectors
  • bioinformatics: construction of databases on genomes, protein sequences; modelling complex biological processes, including systems biology
  • nanobiotechnology: applies the tools and processes of nano/microfabrication to build devices for studying biosystems and applications in drug delivery, diagnostics etc.

This Class Excludes (Cross-References)

0

—

02 / REGULATORY & TAX DOSSIER

Legislation, Licensing, Incorporation & Tax Framework

Div. 72 • Sec. N

Governing Statutes & Regulations

R&D & Design Incentives Law No. 5746 Technology Development Zones Law No. 4691 (Teknokent) Industrial Property Law No. 6769 (Patents & Employee Inventions) OHS & Biosafety Regulations

Mandatory Permits, Licenses & Authorities

  • No license required for desk/theoretical R&D; Law 5746 R&D Center certification requires 15–30+ FTE researchers inside dedicated facilities.
  • Clinical trials (CROs) require TİTCK Clinical Research Approval; genetic/biosafety labs follow Law No. 5977 & Biosafety regulations.

Incorporation Route & Chamber Registration

EU NACE Rev. 2.1 Framework
NACE Rev. 2.1 merged 72.11 Biotech & 72.19 into unified 72.10! EU entities access Horizon Europe grants, OECD Frascati Manual R&D standards, and Clinical Trials Reg. (EU) 536/2014.
United States (IRS / SBA / NAICS)
Maps to NAICS 5417. Deep-tech labs tap federal SBIR/STTR non-dilutive grants and IRS IRC § 41 R&D Tax Credit (allowing eligible startups up to $500k/yr payroll-tax offset alongside § 174 rules).
United Kingdom (Companies House / HMRC)
Directly unlocks UK R&D Intensive SME Relief (ERIS) cash tax credits, the 10% UK Patent Box, and Innovate UK grants under UK SIC 72xxx.

VAT, Withholding & Statutory Incentives

  • MAXIMUM TAX RELIEF STACK: Eligible R&D spending unlocks 100% Super-Deduction + 80–95% Payroll Income-Tax Withholding Relief + 50% SGK Employer Share subsidy under Law 5746, plus Teknokent Law 4691 100% profit exemption and 50% Patent Box exemption (KVK Art. 5/B)!
  • Eligible for KOSGEB Business Development (1.5M+ TL) and TÜBİTAK TEYDEB / 1512 BİGG non-dilutive R&D grants.

Cross-Border Regulatory Frameworks (EU / US / UK)

TR • Corporate & Tradesmen Registry

Chamber of Commerce or Industry — Corporate entity standard for R&D grants, patent ownership, and VC equity.

EU / Global Technical Alignment

NACE Rev. 2.1 merged 72.11 Biotech & 72.19 into unified 72.10! EU entities access Horizon Europe grants, OECD Frascati Manual R&D standards, and Clinical Trials Reg. (EU) 536/2014.

AUDIT & BOUNDARY CHECK

Classification Boundaries & Audit Risks

  • Routine QA/certification testing belongs in 71.20, and commercial market polling sits in 73.20 — NOT Div. 72 R&D.
  • Commercializing an invented product into mass manufacturing requires adding the applicable Div. 10–32 production code alongside R&D.
04 / INTERNATIONAL CROSSWALK & MCC

Global Classification Passport

Verified structural and concordance mappings across EU, US, UK, UN, and national registries.

Payment Processing & ISO 18245 MCC Profile

Visa / Mastercard ISO 18245
MCC 8731
Low Risk Tier
Testing Laboratories (Non-Medical) & R&D

Low-risk B2B laboratory, certification, and contract R&D billing.

05 / BOUNDARIES & COMPARISON

Critical Distinctions & Sibling Codes

Open Full Comparison Tool →

Critical Regulatory & Scope Boundaries vs. Adjacent Codes

Critical Regulatory & Scope Boundaries vs. Adjacent Codes
Compared CodeScope BoundaryRegulatory & Tax Impact
62.10 — Software Engineering → Fundamental experimental science/deep-tech discovery is 72.10; commercial software app delivery is 62.10.Both enjoy high-tech priority; wet labs trigger biosafety/clinical approvals.
06 / TAXONOMY TREE

Classification Hierarchy & Data Export

  1. M Professional, scientific and technical activities
  2. 72110 Research and experimental development on biotechnology
07 / FAQ

Frequently Asked Questions

What business activities and models fall under UK SIC 2007 72110?

72110 (Research and experimental development on biotechnology): Research and experimental development on biotechnology; DNA/RNA: genomics, pharmacogenomics, gene probes, genetic engineering, DNA/RNA sequencing/synthesis/amplification, gene expression profiling, and use of antisense technology; proteins and other molecules: sequencing/synthesis/engineering of proteins and peptides (including large molecule hormones); improved delivery methods for large molecule drugs; proteomics, protein isolation and purification, signalling, identification of cell receptors. Typical operators: Biotech, pharma discovery, AI/quantum, materials, and engineering R&D firms (72.10); Contract Research Organizations (CROs), university spinouts, and deep-tech labs.

What regulatory licensing and tax rules apply to 72110 across EU, US, UK, or Turkey?

EU: NACE Rev. 2.1 merged 72.11 Biotech & 72.19 into unified 72.10! EU entities access Horizon Europe grants, OECD Frascati Manual R&D standards, and Clinical Trials Reg. (EU) 536/2014. US: Maps to NAICS 5417. Deep-tech labs tap federal SBIR/STTR non-dilutive grants and IRS IRC § 41 R&D Tax Credit (allowing eligible startups up to $500k/yr payroll-tax offset alongside § 174 rules). UK: Directly unlocks UK R&D Intensive SME Relief (ERIS) cash tax credits, the 10% UK Patent Box, and Innovate UK grants under UK SIC 72xxx.

How does 72110 differ legally from 62.10 (62.10 — Software Engineering)?

Fundamental experimental science/deep-tech discovery is 72.10; commercial software app delivery is 62.10. Regulatory impact: Both enjoy high-tech priority; wet labs trigger biosafety/clinical approvals.

What are the international classification equivalents and MCC code for 72110?

Verified concordance for 72110: Payment MCC 8731 (Testing Laboratories (Non-Medical) & R&D).